Preparation method of core-shell microneedle patch loaded with double nanoparticles
By preparing a core-shell microneedle patch containing silica nanoparticles loaded with oxyhemoglobin and Ce6 and calcium carbonate nanoparticles loaded with aPD-1 antibody, the immune system is activated, solving the problems of large trauma to normal tissue and poor treatment effect of existing melanoma treatments, and achieving efficient and non-invasive tumor treatment.
Patent Information
- Application Number
- CN202610491283.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-04-14
- Publication Date
- 2026-06-30
AI Technical Summary
Existing treatments for melanoma, such as surgery, chemotherapy, and radiotherapy, cause damage to normal tissues and are often ineffective due to drug resistance. Immunotherapy has limited effectiveness and benefits only a small number of patients.
Core-shell microneedle patches were prepared using silica nanoparticles loaded with oxyhemoglobin and Ce6 and calcium carbonate nanoparticles loaded with aPD-1 antibody. By constructing the core-shell structure of the microneedles, the nanoparticles were used to activate the immune system in response to the tumor microenvironment, thereby achieving tumor therapy.
Ultrasound-assisted therapy can effectively treat large or deep-seated tumors, reduce damage to normal tissues, improve the therapeutic efficiency of immune checkpoint inhibitors, alleviate the problems of high glutathione content and low pH in the tumor microenvironment, and protect the activity of aPD-1 antibodies.